Use of cell membrane permeants in the treatment of cellular proliferative diseases
CA 2247481 A1 · Owner: Matrix Pharmaceutical, Inc. · Inventors: Singh, Saira; Jones, Richard E.; Brown, Dennis M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods are provided for the treatment of a host suffering from a cellular proliferative disease through administration of a chemotherapeutic agent in conjunction with a cell membrane permeant. Optionally the cell membrane , permeant and/or chemotherapeutic agent will be present in a pharmaceutically acceptable vehicle capable of acting as a depot. In the subject methods the , chemotherapeutic agent and membrane permeant are administered at least proximal to a target site of the host. Administration of chemotherapeutic agents in accordance with the subject methods results in improved efficacy of and/or decreased host toxicity to, the intralesionally administered chemotherapeutic agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 14, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 14, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 14, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.